Will Multi-Parametric Magnetic Resonance Imaging be the Future Tool to Detect Clinically Significant Prostate Cancer?

Editorial: Prostate Cancer: What We Know and What We Would Like to Know. Front Oncol (2015) 0.75

Prostate-cancer mortality at 11 years of follow-up. N Engl J Med (2012) 16.91

ESUR prostate MR guidelines 2012. Eur Radiol (2012) 8.86

Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol (2014) 4.56

Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol (2012) 3.30

Overdiagnosis and overtreatment of prostate cancer. Eur Urol (2014) 3.25

Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol (2013) 2.62

The contemporary concept of significant versus insignificant prostate cancer. Eur Urol (2011) 2.29

Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. J Urol (2014) 2.07

Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment. J Urol (2014) 1.55

Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study. Radiology (2013) 1.50

Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol (2013) 1.41

Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. Radiology (2013) 1.39

Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI. AJR Am J Roentgenol (2013) 1.35

Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy. Radiology (2014) 1.28

The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer? Urol Oncol (2013) 1.25

The role of magnetic resonance imaging in the diagnosis and management of prostate cancer. BJU Int (2013) 1.19

Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score. Clin Cancer Res (2014) 1.06

Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard. Prostate Cancer Prostatic Dis (2013) 1.05

MR imaging of the prostate. Radiol Clin North Am (2014) 0.98

Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study. Urol Int (2011) 0.98

Prostate cancer: diffusion-weighted imaging versus dynamic-contrast enhanced imaging for tumor localization-a meta-analysis. J Comput Assist Tomogr (2013) 0.93

Standardization of multiparametric prostate MR imaging using PI-RADS. Biomed Res Int (2014) 0.88

Diffusion-weighted magnetic resonance imaging detects significant prostate cancer with high probability. J Urol (2014) 0.87

The role of MRI in active surveillance of prostate cancer. Curr Opin Urol (2013) 0.87